Imperial Brands/£IMB

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Imperial Brands

Imperial Brands PLC is a multinational tobacco company based in Bristol, United Kingdom. It operates in the tobacco industry, manufacturing and distributing a wide range of tobacco and nicotine products. Its core segments include cigarettes, fine-cut tobacco, cigars, and the growing next-generation products category, which encompasses e-cigarettes and heated tobacco products. Founded in 1901 as the Imperial Tobacco Company, it has evolved through various mergers and acquisitions to become a prominent global player. The company operates in several regions worldwide, with a significant presence in Europe, the Americas, and Asia. Imperial Brands focuses on leveraging its portfolio of well-known brands, operational efficiencies, and strategic investments in reduced-risk products to maintain its market position.

Ticker

£IMB

Primary listing

LSE

Employees

25,600

Imperial Brands Metrics

BasicAdvanced
£24B
10.08
£3.02
0.30
£1.89
6.19%

What the Analysts think about Imperial Brands

Analyst ratings (Buy, Hold, Sell) for Imperial Brands stock.

Bulls say / Bears say

Next-generation product net revenue rose 15.4% in H1 FY25 with growth across all categories and a 14% reduction in NGP operating losses, demonstrating successful portfolio diversification (Imperial Brands H1 Results).
The group generated £2.4 billion of free cash flow over 12 months with 99% conversion, funding a £1.25 billion share buyback and an increased interim dividend, underscoring strong cash generation and capital return capacity (Imperial Brands H1 Results).
Imperial announced a £1.45 billion share buyback for FY26 alongside progressive dividends, projecting total shareholder returns exceeding £2.7 billion next year and signaling management’s confidence in sustained growth (Reuters).
Tobacco volumes declined by 3.2% in H1 FY25 despite strong pricing, highlighting structural demand erosion in its core combustible business (Imperial Brands H1 Results).
The U.S. FDA issued a marketing denial order for blu disposable vape in August 2025, blocking its distribution and undermining next-generation product growth in a key market (Tobacco Insider).
Unexpected CEO transition with Stefan Bomhard’s retirement and Lukas Paravicini’s appointment on October 1, 2025 injects leadership uncertainty, posing execution risk for new strategic initiatives (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Nov 2025.

Imperial Brands Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Imperial Brands Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £IMB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs